World's Best Scientists 2026 revealed!
R. Jeffrey Karnes

R. Jeffrey Karnes

D-Index & Metrics

Medicine

D-Index
90
Citations
26504
World Ranking
12314
National Ranking
6307

R. Jeffrey Karnes publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where R. Jeffrey Karnes sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 745 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

R. Jeffrey Karnes D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where R. Jeffrey Karnes sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 90 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

R. Jeffrey Karnes is affiliated with the Mayo Clinic in the United States and has an extensive publication record primarily focused on medicine, with emphasis on pulmonary and respiratory medicine, surgery, radiology, nuclear medicine and imaging, cancer research, and urology.

The scientist's research interests center on prostate cancer treatment and research, with significant attention also given to prostate cancer diagnosis and treatment. Other areas of study include bladder and urothelial cancer treatments, urinary and genital oncology studies, urological disorders and treatments, urologic and reproductive health conditions, as well as cancer, lipids, and metabolism.

Karnes has contributed to multiple papers, including the following recent publications:

  • Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019 (2020), Journal of Clinical Oncology
  • Prostate Cancer, Version 3.2024 (2024), Journal of the National Comprehensive Cancer Network
  • A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer (2020), European Urology
  • Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic (2020), European Urology
  • MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets (2022), Nature Communications

The frequent coauthors in Karnes's body of work include Alberto Briganti, Stephen A. Boorjian, Francesco Montorsi, Giorgio Gandaglia, and Matthew K. Tollefson. These collaborators collectively contribute to a robust network of research within urologic oncology and related fields.

Publication venues where Karnes has appeared regularly include:

  • The Journal of Urology (67 publications)
  • European Urology Open Science (33 publications)
  • European Urology (24 publications)
  • Urologic Oncology Seminars and Original Investigations (20 publications)
  • Journal of Clinical Oncology (18 publications)

Karnes's research contributes primarily to the medical fields with a particular focus on cancer, surgery, and diagnostic imaging related to urologic and prostate cancer issues.

Best Publications

  • Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy

    Nicholas Erho;Anamaria Crisan;Ismael A. Vergara;Anirban P. Mitra

  • Long-Term Outcome After Radical Prostatectomy for Patients With Lymph Node Positive Prostate Cancer in the Prostate Specific Antigen Era

    Stephen A. Boorjian;R. Houston Thompson;Sameer Siddiqui;Stephanie Bagniewski

  • Long-Term Risk of Clinical Progression After Biochemical Recurrence Following Radical Prostatectomy: The Impact of Time from Surgery to Recurrence

    Stephen A. Boorjian;R. Houston Thompson;Matthew K. Tollefson;Laureano J. Rangel

  • Metastasis-directed Therapy of Regional and Distant Recurrences After Curative Treatment of Prostate Cancer: A Systematic Review of the Literature

    Piet Ost;Alberto Bossi;Karel Decaestecker;Gert De Meerleer

  • Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an At Risk Patient Population

    R. Jeffrey Karnes;Eric J. Bergstralh;Elai Davicioni;Mercedeh Ghadessi

  • B7-H3 Ligand Expression by Prostate Cancer: A Novel Marker of Prognosis and Potential Target for Therapy

    Timothy J. Roth;Yuri Sheinin;Christine M. Lohse;Susan M. Kuntz

  • Long-Term Survival After Radical Prostatectomy Versus External Beam Radiotherapy for Patients with High-Risk Prostate Cancer

    Stephen A. Boorjian;R. Jeffrey Karnes;Rosalia Viterbo;Laureano J. Rangel

  • Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature.

    Daher C. Chade;Daher C. Chade;James Eastham;Markus Graefen;Jim C. Hu

  • Mayo Clinic Validation of the D’Amico Risk Group Classification for Predicting Survival Following Radical Prostatectomy

    Stephen A Boorjian;R Jeffrey Karnes;Laureano J Rangel;Eric J Bergstralh

  • A Critical Analysis of the Long-Term Impact of Radical Prostatectomy on Cancer Control and Function Outcomes

    Stephen A. Boorjian;James A. Eastham;Markus Graefen;Bertrand Guillonneau

  • Efficiency, Satisfaction, and Costs for Remote Video Visits Following Radical Prostatectomy: A Randomized Controlled Trial

    Boyd R. Viers;Deborah J. Lightner;Marcelino E. Rivera;Matthew K. Tollefson

  • Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients

    Paolo Gontero;Richard Sylvester;Francesca Pisano;Steven Joniau

  • Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy.

    Shuang G. Zhao;S. Laura Chang;Nicholas Erho;Menggang Yu

  • RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1

    John R Prensner;Shuang Zhao;Nicholas Erho;Matthew Schipper

  • A Comparison of BTA Stat, Hemoglobin Dipstick, Telomerase and Vysis Urovysion Assays for the Detection of Urothelial Carcinoma in Urine

    Kevin C. Halling;Walter King;Irina A. Sokolova;R. Jeffrey Karnes

  • Combination of Adjuvant Hormonal and Radiation Therapy Significantly Prolongs Survival of Patients With pT2–4 pN+ Prostate Cancer: Results of a Matched Analysis

    Alberto Briganti;R. Jeffrey Karnes;Luigi Filippo Da Pozzo;Cesare Cozzarini

  • Combined Value of Validated Clinical and Genomic Risk Stratification Tools for Predicting Prostate Cancer Mortality in a High-risk Prostatectomy Cohort

    Matthew R. Cooperberg;Elai Davicioni;Anamaria Crisan;Robert B. Jenkins

  • Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration.

    Daher C. Chade;Daher C. Chade;Shahrokh F. Shariat;Shahrokh F. Shariat;Angel M. Cronin;Caroline J. Savage

  • Stratification of High-risk Prostate Cancer into Prognostic Categories: A European Multi-institutional Study.

    Steven Joniau;Alberto Briganti;Paolo Gontero;Giorgio Gandaglia

  • Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis

    Shuang G. Zhao;S. Laura Chang;Daniel E. Spratt;Nicholas Erho

Frequent Co-Authors

Alberto Briganti
Alberto Briganti Vita-Salute San Raffaele University
Francesco Montorsi
Francesco Montorsi Vita-Salute San Raffaele University
Steven Joniau
Steven Joniau KU Leuven
Giorgio Gandaglia
Giorgio Gandaglia Vita-Salute San Raffaele University
Edward M. Schaeffer
Edward M. Schaeffer Northwestern University
Eric A. Klein
Eric A. Klein Cleveland Clinic
John C. Cheville
John C. Cheville Mayo Clinic
Michael L. Blute
Michael L. Blute Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a medical career in the USA, there are many flexible and accessible education pathways available online. Growing demand for nursing professionals means online programs now offer accelerated and affordable options to launch or advance your career.

For those interested in leadership or advanced practice roles, accelerated dnp programs online allow you to earn a Doctor of Nursing Practice degree in less time than traditional formats. Candidates seeking cost-effective solutions can explore cheapest dnp programs, which provide rigorous education at a lower tuition rate.

If you want to start working sooner, fast track lpn programs online help students quickly qualify as Licensed Practical Nurses through concentrated coursework. Those interested in mental health specialties might consider the shortest online pmhnp programs to become a Psychiatric-Mental Health Nurse Practitioner efficiently.

Online healthcare degrees provide diverse routes for career advancement and entry, catering to different backgrounds and professional ambitions.

Best Scientists Citing R. Jeffrey Karnes

Trending Scientists

Recently Published Articles